[An update of the recommendations of the Spanish Neonatology Society for the use of palivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants].

An Pediatr (Engl Ed)

Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address:

Published: November 2019

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.anpedi.2019.08.003	DOI Listing

Publication Analysis

[an update

update recommendations

recommendations spanish

spanish neonatology

neonatology society

society palivizumab

palivizumab prophylaxis

prophylaxis severe

severe infections

infections syncytial

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!